A disease structured and drug centric unique data set combining all new science gathered from multi-language articles, preprints, abstracts, journals, global conference presentations and KOL social media channels with proprietary information on funding, production capacity, supply and pricing.
An intelligence solution updated in real time with weekly detailed reports, daily newsletters, breaking alerts and direct access to expert analysts.
Track the latest life science innovations globally in real time and leverage a powerful combination of advanced data science and deep domain expertise to ensure your critical business decisions are made with speed, accuracy and certainty.
Through Science360’s structured real time data aggregation and predictive forecasting capabilities you receive an unbiased view of new drug candidates’ success likelihood and can immediately identify high impact upcoming research. The facility to dive deeper into the underlying science and consult with our dedicated analysts helps you isolate the actionable information and insights.
The Science360 experience
We combine automated global monitoring of new science, broader health and alternative data, traditional and social media with multiple human Q&A processes and real time analysis by therapy area specialists. This “human + machine” approach has the benefit of delivering both large scale listening and data collation capabilities with accurate expert driven predictive modelling.
In addition to full access to the Science360 platform for your team, you receive deep-dive reports on the most timely and relevant developments in the field in your inbox. For the full 360° experience, you have direct access to our team of analysts and tailored reports for your business to gain a competitive edge.
Who uses the platform today?
National defense and health departments, NGOs, pharmaceuticals, hedge funds, industry bodies and their corporate members rely on Airfinity’s platform to understand scientific progress as it unfolds.
Airfinity has been critical in furnishing us and the rest of the world with COVID-19 numbers
James Fransham, Data Journalist
You are helping us make better decisions
Commercial Lead, Bayer
Airfinity has been instrumental in our country’s COVID response
Head of Government Vaccine Task Force
Vaccine production data from Airfinity has been spot on and its forecasts have been extremely correct. In a fast moving pandemic, these forecasts are really important for evidence-based policy making
Director General, IFPMA
The Airfinity report is a guide for world leaders to fix a more ambitious action plan. It shows we have enough vaccines either on shelves or in production even to vaccinate 70% of the global population by May next year
Gordon Brown, WHO Ambassador for Global Health Financing and former UK Prime Minister
We deliver critical data, information and insights to global decision makers across pharmaceuticals, med- and biotech companies, governments, corporates and investors.
Our experts will:
Complete the form to schedule your demo.